Deals
Deals dated after 30 September 2026 are still being collected.
Columns
3 of 3 deals
| Advisers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 2026 | Alesta Therapeutics | – | BioMarin Pharmaceutical | Acquisition | Legal adviser to Alesta Therapeutics (target) | Announced | 275.0 | Biotech+2 | Morgan Stanley (buy-side)Jones Day (buy-side)J.P. Morgan (sell-side)Goodwin (sell-side) | BioMarin Pharmaceutical acquisition of Alesta Therapeutics |
| Jun 2026 | INNIO | AI Alpine (Luxembourg) S.à r.l. | – | IPO | Legal adviser to the issuer | Announced | 2,430.0 | Manufacturing+1 | Goldman Sachs (lead manager)J.P. Morgan (lead manager)Morgan Stanley (lead manager)BofA Securities (lead manager)Citi (lead manager)Baird (lead manager)BNP Paribas (lead manager)Deutsche Bank (lead manager)RBC Capital Markets (lead manager)UBS (lead manager)Crédit Agricole CIB (lead manager)Erste Group (lead manager)UniCredit (lead manager)Academy Securities (lead manager)Drexel Hamilton (lead manager)Latham & Watkins (issuer)Milbank (lead manager)De Brauw Blackstone Westbroek (lead manager)Barclays (lead manager) | INNIO IPO |
| Nov 2025 | Axalta Coating Systems | – | – | Merger | Legal adviser to Axalta Coating Systems (target) | Pending | – | Chemicals+2 | Morgan Stanley (buy-side)De Brauw Blackstone Westbroek (buy-side)Davis Polk (buy-side)FGS Global (buy-side)Lazard (buy-side)Evercore (sell-side)J.P. Morgan (sell-side)Cravath, Swaine & Moore (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side)Gilbert + Tobin (sell-side)Walkers (sell-side) | Akzo Nobel and Axalta Coating Systems merger |
Activity
By announcement date; raisings and IPOs by their own date.
Sector of the business bought or funded.
Disclosed value in US dollars.
Most often across the table
- Morgan Stanley
2 dealsCompare - Jones Day
1 dealCompare - De Brauw Blackstone Westbroek1 dealCompare
- Davis Polk
1 dealCompare - FGS Global1 dealCompare
- Lazard
1 dealCompare
Firms advising the other side of the same deals.